Research in fibrinolysis and proteolysis is focusing on extracellular matrix degradation and vascular biology

Fibrinolysis and Proteolysis

Volumn 13, Issue 2, 1999, Pages 47-48

  Blinc, A ^a   Fras, Z ^a   Stegnar, M ^a   Keber, D ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; BLOOD CLOT LYSIS; CELL DEATH; EDITORIAL; EXTRACELLULAR MATRIX; FIBRINOLYSIS; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; RESEARCH;

EID: 0033058919     PISSN: 13690191     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(99)90078-4     Document Type: Editorial

References (14)

1. Nesheim ME. TAFI. Fibrinolysis & Proteolysis 1999; 13(2): 72-77.
2. Galis ZS. Metalloproteases in remodeling of vascular extracellular matrix. Fibrinolysis & Proteolysis 1999; 13(2): 54-63.
3. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126.
4. Plow EF, Ploplis VA, Carmeliet P, Collen D. Plasminogen and cell migration in vivo. Fibrinolysis & Proteolysis 1999; 13(2): 49-53.
5. Indyk JA, Chen ZL, Strickland S. Proteases and degradation of extracellular matrix in neurodegeneration. Fibrinolysis & Proteolysis 1999; 13(2): 64-71.
6. Lowe GDO, Rumley A. Coagulation, fibrinolysis and cardiovascular disease. Fibrinolysis & Proteolysis 1999; 13(2): 91-98.
7. Pislaru SV, Van de Werf F. The current role of thrombolytic therapy in the treatment of acute myocardial infarction. Fibrinolysis & Proteolysis 1999; 13(2): 78-90.
8. Carmeliet P, Moons L, Dewerschein M et al. Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor and the plasminogen system. Ann NY Acad Sci 1997, 811: 191-206.
9. Carmeliet P. Insights from gene inactivation studies of the coagulation and plasminogen. Fibrinolysis & Proteolysis 1997; 11(suppl 2): 181-191.
10. Carmeliet P, Collen D. Tissue factor. Int J Biochem Cell Biol 1998; 30: 661-716.
11. Carmeliet P, Moons L, Collen D. Mouse models of angiogenesis, arterial stenosis, atherosclerosis and haemostasis. Cardiovascular Res 1998; 39: 8-33.
12. Hewitt R, Dano K. Stromal cell expression of components of matrix degrading protease systems in human cancer. Enzyme Protein 1996; 49: 163-173.
13. Johnson M, Lund LR, Romer J, Almholt K, Dano K. Cancer invasion and tissue remodeling: common theme is proteolytic matrix degradation. Curr Opin Cell Biol 1998; 10: 667-671.
14. Behrendt N, Stephens RW. The urokinase receptor. Fibrinolysis & Proteolysis 1998; 12: 191-204.